JUSTYNA PACHOWSKA: Open Payments
NPI 1619421518 · AVON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,188 in 135 payments from 19 companies in 2025. Trend: 2023 $1,255 · 2024 $1,839 · 2025 $3,188
Food & beverage: $3,178Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $761 |
| UCB, Inc. | 16 | $576 |
| Amgen Inc. | 11 | $344 |
| LEO Pharma Inc. | 9 | $237 |
| PFIZER INC. | 8 | $187 |
| Galderma Laboratories, L.P. | 5 | $178 |
| GENZYME CORPORATION | 5 | $143 |
| Lilly USA, LLC | 15 | $140 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $123 |
| Janssen Biotech, Inc. | 4 | $118 |
Products named: Bimzelx, RINVOQ, OTEZLA, SKYRIZI, ADBRY, DUPIXENT, CIBINQO, NEMLUVIO.
Industry payments across CT — which companies pay providers there.
